Patil, Seema A.
Flasar, Mark H.
Lin, Jay
Lingohr-Smith, Melissa
Skup, Martha
Wang, Song
Chao, Jingdong
Cross, Raymond K.
Funding for this research was provided by:
AbbVie
Article History
Received: 22 May 2018
Accepted: 3 October 2018
First Online: 11 October 2018
Compliance with ethical standards
:
: Seema Patil has no conflicts of interest to report. Mark Flasar participates in advisory boards for Janssen and Prometheus Labs. Jay Lin is an employee of Novosys Health, which received payment from AbbVie for this research analysis. Melissa Lingohr-Smith is an employee of Novosys Health, which received payment from AbbVie for this research analysis. Martha Skup is an employee of AbbVie and may own stock or stock options. Song Wang is a former employee of AbbVie and may own stock or stock options. Jingdong Chao is a former Employee of AbbVie and may own stock or stock options. Raymond Cross receives consulting fees from/for AbbVie; participates in advisory boards for AbbVie, Janssen, Pfizer, and Takeda; and has a research grant with AbbVie.